60 DEGREES PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

40 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Extension to Engagement Agreement
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2025
Engagement Agreement
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2025
Amendment to Engagement Agreement
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2025
Form of Series B Warrants
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2024
Form of Series A Warrants
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2024
Description of the Registrants' Securities
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2024
Board of Directors Agreement dated as of December 15, 2022, as amended, by and between the Registrant and Paul Field
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Board of Directors Agreement dated as of December 9, 2022, as amended, by and between the Registrant and Cheryl Xu
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Board of Directors Agreement dated as of November 28, 2022, as amended, by and between the Registrant and Stephen Toovey
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Board of Directors Agreement dated as of November 28, 2022, as amended, by and between the Registrant and Charles Allen
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Note Extension Agreement dated as of May 18, 2023, by and between the Registrant and Mountjoy Trust
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Note Extension Agreement dated as of May 18, 2023, by and between the Registrant and the Geoffrey S. Dow Revocable Trust
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Walleye Opportunities Master Fund Ltd
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Cavalry Investment Fund, LP
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Bigger Capital Fund, LP
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Form of Common Stock Purchase Warrant to be issued by the Registrant to WallachBeth Capital LLC
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Common Stock Purchase Warrant dated as of May 8, 2023, issued by the Registrant to Sabby Volatility Warrant Master Fund, Ltd
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Form of Underwriting Agreement
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2023
Agreement to Convert Debt to Equity dated as of August 31, 2021, issued by the Registrant to Douglas Loock
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Master Consultancy Agreement dated as of May 29, 2013, by and between the Registrant and BioIntelect Pty Ltd
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
FL
2023
Second Amendment to The Debt Conversion Agreement dated as of January 27, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
First Amendment to the Debt Conversion Agreement dated as of January 19, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Debt Conversion Agreement dated as of January 9, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Agreement to Convert Debt to Equity dated as of August 31, 2021, issued by the Registrant to Douglas Loock
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Master Consultancy Agreement dated as of May 29, 2013, by and between the Registrant and BioIntelect Pty Ltd
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
FL
2023
Second Amendment to The Debt Conversion Agreement dated as of January 27, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
First Amendment to the Debt Conversion Agreement dated as of January 19, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Debt Conversion Agreement dated as of January 9, 2023, by and between the Registrant to Knight Therapeutics International S.A
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
2023
Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation
60 DEGREES PHARMACEUTICALS, INC.
Pharmaceuticals
FL
2023